Categories AlphaGraphs, Cannabis, Earnings
TLRY Earnings: Highlights of Tilray’s Q2 2023 financial results
Cannabis company Tilray (NASDAQ: TLRY) has announced financial results for the second quarter of 2023, reporting a net loss and a 7% decrease in revenues.
The company reported a net loss of $61.6 million or $0.11 per share for the three months ended November 2022, compared to a profit of $5.8 million or breakeven per share in the prior-year period. Cannabis gross profit Increased by 37% to around $19 million.
The bottom line was negatively impacted by a 7% decline in revenues to $144.2 million. At $11.7 million, adjusted EBITDA was down 15%.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
